S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
BREAKING: Tiny biotech successfully treats blindness (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
BREAKING: Tiny biotech successfully treats blindness (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
BREAKING: Tiny biotech successfully treats blindness (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
BREAKING: Tiny biotech successfully treats blindness (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
BREAKING: Tiny biotech successfully treats blindness (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
BREAKING: Tiny biotech successfully treats blindness (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
BREAKING: Tiny biotech successfully treats blindness (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
BREAKING: Tiny biotech successfully treats blindness (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
OTCMKTS:LCSHF

Lancashire (LCSHF) Price Target & Analyst Ratings

$7.45
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$7.45
$7.45
50-Day Range
$7.00
$8.05
52-Week Range
$4.98
$8.05
Volume
N/A
Average Volume
1,650 shs
Market Capitalization
N/A
P/E Ratio
7.24
Dividend Yield
2.01%
Price Target
N/A

Lancashire Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Reduce
Based on 3 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
9/30/22 to 9/30/23
1 Month Ago
8/31/22 to 8/31/23
3 Months Ago
7/2/22 to 7/2/23
1 Year Ago
9/30/21 to 9/30/22
Consensus Rating
Reduce
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
7 Buy rating(s)
Hold
2 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Predicted UpsideN/AN/AN/AN/A
Get Lancashire Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for LCSHF and its competitors with MarketBeat's FREE daily newsletter.


LCSHF Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LCSHF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lancashire Stock vs. The Competition

TypeLancashireFinancial Services CompaniesS&P 500
Consensus Rating Score
1.67
2.42
2.49
Consensus RatingReduceHoldHold
Predicted Upside725.24% Upside698.21% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/22/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral
9/7/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetGBX 670 ➝ GBX 680
9/5/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight
8/14/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetGBX 780 ➝ GBX 770
12/6/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform
11/8/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetGBX 760 ➝ GBX 770
11/7/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetGBX 550 ➝ GBX 600
(Data available from 9/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












LCSHF Price Target - Frequently Asked Questions

What is Lancashire's consensus rating?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Lancashire stock is Reduce based on the current 1 sell rating and 2 hold ratings for LCSHFthe . Learn more on LCSHF's analyst rating history.

Do Wall Street analysts like Lancashire more than its competitors?

Analysts like Lancashire less than other Financial Services companies. The consensus rating for Lancashire is Reduce while the average consensus rating for financial services companies is Hold. Learn more on how LCSHF compares to other companies.

Is Lancashire being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Lancashire's stock had 1 upgrade and 1 downgrade by analysts.

What analysts cover Lancashire?

Lancashire has been rated by Barclays, Berenberg Bank, JPMorgan Chase & Co., and Morgan Stanley in the past 90 days.


Stock Ratings Reports and Tools

This page (OTCMKTS:LCSHF) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -